{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:53:12Z","timestamp":1793040792350,"version":"4.5.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T00:00:00Z","timestamp":1680220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T00:00:00Z","timestamp":1680220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s10753-023-01805-6","type":"journal-article","created":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T11:41:54Z","timestamp":1680608514000},"page":"1255-1271","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Specific Activation of CB2R Ameliorates Psoriasis-Like Skin Lesions by Inhibiting Inflammation and Oxidative Stress"],"prefix":"10.1007","volume":"46","author":[{"given":"Yufeng","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglin","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qunfang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianqiong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renshan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,31]]},"reference":[{"issue":"2","key":"1805_CR1","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3390\/antiox11020282","volume":"11","author":"EC Dobric\u0103","year":"2022","unstructured":"Dobric\u0103, E.C., M.A. Cozma, M.A. G\u0103man, et al. 2022. The Involvement of Oxidative Stress in Psoriasis: A Systematic Review. Antioxidants 11 (2): 282. https:\/\/doi.org\/10.3390\/antiox11020282.","journal-title":"Antioxidants"},{"issue":"9997","key":"1805_CR2","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/s0140-6736(14)61909-7","volume":"386","author":"W-H Boehncke","year":"2015","unstructured":"Boehncke, W.-H., and M.P. Sch\u00f6n. 2015. Psoriasis. The Lancet 386 (9997): 983\u2013994. https:\/\/doi.org\/10.1016\/s0140-6736(14)61909-7.","journal-title":"The Lancet"},{"issue":"19","key":"1805_CR3","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020.4006","volume":"323","author":"AW Armstrong","year":"2020","unstructured":"Armstrong, A.W., and C. Read. 2020. Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review. Journal of American Medical Association 323 (19): 1945\u20131960. https:\/\/doi.org\/10.1001\/jama.2020.4006.","journal-title":"Journal of American Medical Association"},{"issue":"6","key":"1805_CR4","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.3390\/ijms20061475","volume":"20","author":"A Rendon","year":"2019","unstructured":"Rendon, A., and K. Schakel. 2019. Psoriasis Pathogenesis and Treatment. International Journal of Molecular Sciences 20 (6): 1475. https:\/\/doi.org\/10.3390\/ijms20061475.","journal-title":"International Journal of Molecular Sciences"},{"key":"1805_CR5","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.bcp.2018.08.022","volume":"157","author":"CD Rio","year":"2018","unstructured":"Rio, C.D., E. Millan, V. Garcia, et al. 2018. The endocannabinoid system of the skin. A potential approach for the treatment of skin disorders. Biochemical Pharmacology 157: 122\u2013133. https:\/\/doi.org\/10.1016\/j.bcp.2018.08.022.","journal-title":"Biochemical Pharmacology"},{"issue":"2","key":"1805_CR6","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jdermsci.2015.11.005","volume":"81","author":"A G\u0119gotek","year":"2016","unstructured":"G\u0119gotek, A., M. Biernacki, E. Ambro\u017cewicz, et al. 2016. The cross-talk between electrophiles, antioxidant defence and the endocannabinoid system in fibroblasts and keratinocytes after UVA and UVB irradiation. Journal of Dermatological Science 81 (2): 107\u2013117. https:\/\/doi.org\/10.1016\/j.jdermsci.2015.11.005.","journal-title":"Journal of Dermatological Science"},{"issue":"6","key":"1805_CR7","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.bpsc.2020.07.016","volume":"6","author":"HC Lu","year":"2021","unstructured":"Lu, H.C., and K. Mackie. 2021. Review of the Endocannabinoid System. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging 6 (6): 607\u2013615. https:\/\/doi.org\/10.1016\/j.bpsc.2020.07.016.","journal-title":"Biological Psychiatry: Cognitive Neuroscience and Neuroimaging"},{"key":"1805_CR8","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3389\/fnins.2016.00243","volume":"10","author":"E Aso","year":"2016","unstructured":"Aso, E., and I. Ferrer. 2016. CB2 Cannabinoid Receptor As Potential Target against Alzheimer\u2019s Disease. Frontiers in Neuroscience 10: 243. https:\/\/doi.org\/10.3389\/fnins.2016.00243.","journal-title":"Frontiers in Neuroscience"},{"issue":"2","key":"1805_CR9","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3390\/ph15020210","volume":"15","author":"AM Martins","year":"2022","unstructured":"Martins, A.M., A.L. Gomes, I. Vilas Boas, et al. 2022. Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review. Pharmaceuticals 15 (2): 210. https:\/\/doi.org\/10.3390\/ph15020210.","journal-title":"Pharmaceuticals"},{"issue":"1","key":"1805_CR10","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s10020-021-00351-x","volume":"27","author":"X Cheng","year":"2021","unstructured":"Cheng, X., J. Lin, Z. Chen, et al. 2021. CB2-mediated attenuation of nucleus pulposus degeneration via the amelioration of inflammation and oxidative stress in vivo and in vitro. Molecular Medicine 27 (1): 92. https:\/\/doi.org\/10.1186\/s10020-021-00351-x.","journal-title":"Molecular Medicine"},{"issue":"3","key":"1805_CR11","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11357-022-00565-9","volume":"44","author":"M Rajesh","year":"2022","unstructured":"Rajesh, M., P. Mukhopadhyay, S. B\u00e1tkai, et al. 2022. Cannabinoid receptor 2 activation alleviates diabetes-induced cardiac dysfunction, inflammation, oxidative stress, and fibrosis. Geroscience 44 (3): 1727\u20131741. https:\/\/doi.org\/10.1007\/s11357-022-00565-9.","journal-title":"Geroscience"},{"issue":"4","key":"1805_CR12","doi-asserted-by":"publisher","first-page":"549","DOI":"10.4103\/0973-1482.106534","volume":"8","author":"Z Zhao","year":"2012","unstructured":"Zhao, Z., J. Yang, H. Zhao, et al. 2012. Cannabinoid receptor 2 is upregulated in melanoma. Journal of Cancer Research and Therapeutics 8 (4): 549\u2013554. https:\/\/doi.org\/10.4103\/0973-1482.106534.","journal-title":"Journal of Cancer Research and Therapeutics"},{"key":"1805_CR13","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.7717\/peerj.40","volume":"1","author":"Y Ramot","year":"2013","unstructured":"Ramot, Y., K. Sugawara, N. Z\u00e1k\u00e1ny, et al. 2013. A novel control of human keratin expression: cannabinoid receptor 1-mediated signaling down-regulates the expression of keratins K6 and K16 in human keratinocytes in vitro and in situ. PeerJ 1: e40. https:\/\/doi.org\/10.7717\/peerj.40.","journal-title":"PeerJ"},{"issue":"5","key":"1805_CR14","doi-asserted-by":"publisher","first-page":"918","DOI":"10.3390\/molecules24050918","volume":"24","author":"KF Toth","year":"2019","unstructured":"Toth, K.F., D. Adam, T. Biro, et al. 2019. Cannabinoid Signaling in the Skin: Therapeutic Potential of the \u201cC(ut)annabinoid\u201d System. Molecules 24 (5): 918. https:\/\/doi.org\/10.3390\/molecules24050918.","journal-title":"Molecules"},{"key":"1805_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12950-018-0201-z","volume":"15","author":"Y Du","year":"2018","unstructured":"Du, Y., P. Ren, Q. Wang, et al. 2018. Cannabinoid 2 receptor attenuates inflammation during skin wound healing by inhibiting M1 macrophages rather than activating M2 macrophages. Journal of Inflammation 15: 25. https:\/\/doi.org\/10.1186\/s12950-018-0201-z.","journal-title":"Journal of Inflammation"},{"issue":"1","key":"1805_CR16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13075-021-02665-x","volume":"24","author":"S Maddukuri","year":"2022","unstructured":"Maddukuri, S., J. Patel, D.A. Diaz, et al. 2022. Cannabinoid type 2 receptor (CB2R) distribution in dermatomyositis skin and peripheral blood mononuclear cells (PBMCs) and in vivo effects of LenabasumTM. Arthritis Research & Therapy 24 (1): 12. https:\/\/doi.org\/10.1186\/s13075-021-02665-x.","journal-title":"Arthritis Research & Therapy"},{"key":"1805_CR17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.mehy.2016.12.003","volume":"99","author":"AH Norooznezhad","year":"2017","unstructured":"Norooznezhad, A.H., and F. Norooznezhad. 2017. Cannabinoids: Possible agents for treatment of psoriasis via suppression of angiogenesis and inflammation. Medical Hypotheses 99: 15\u201318. https:\/\/doi.org\/10.1016\/j.mehy.2016.12.003.","journal-title":"Medical Hypotheses"},{"key":"1805_CR18","doi-asserted-by":"publisher","first-page":"790712","DOI":"10.3389\/fphar.2022.790712","volume":"13","author":"L Li","year":"2022","unstructured":"Li, L., X. Liu, W. Ge, et al. 2022. CB2R Deficiency Exacerbates Imiquimod-Induced Psoriasiform Dermatitis and Itch Through the Neuro-Immune Pathway. Frontiers in Pharmacology 13: 790712. https:\/\/doi.org\/10.3389\/fphar.2022.790712.","journal-title":"Frontiers in Pharmacology"},{"issue":"6","key":"1805_CR19","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3109\/10715762.2016.1162301","volume":"50","author":"X Lin","year":"2016","unstructured":"Lin, X., and T. Huang. 2016. Oxidative stress in psoriasis and potential therapeutic use of antioxidants. Free Radical Research 50 (6): 585\u2013595. https:\/\/doi.org\/10.3109\/10715762.2016.1162301.","journal-title":"Free Radical Research"},{"issue":"12","key":"1805_CR20","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.3390\/ijms19123805","volume":"19","author":"Q Xue","year":"2018","unstructured":"Xue, Q., Y. Yan, R. Zhang, et al. 2018. Regulation of iNOS on Immune Cells and Its Role in Diseases. International Journal of Molecular Sciences 19 (12): 3805. https:\/\/doi.org\/10.3390\/ijms19123805.","journal-title":"International Journal of Molecular Sciences"},{"issue":"1\u20132","key":"1805_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s004030050268","volume":"290","author":"AD Ormerod","year":"1998","unstructured":"Ormerod, A.D., R. Weller, P. Copeland, et al. 1998. Detection of nitric oxide and nitric oxide synthases in psoriasis. Archives Of Dermatological Research 290 (1\u20132): 3\u20138. https:\/\/doi.org\/10.1007\/s004030050268.","journal-title":"Archives Of Dermatological Research"},{"issue":"3","key":"1805_CR22","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jdermsci.2008.12.012","volume":"54","author":"O Simonetti","year":"2009","unstructured":"Simonetti, O., G. Lucarini, A. Campanati, et al. 2009. VEGF, survivin and NOS overexpression in psoriatic skin: critical role of nitric oxide synthases. Journal of Dermatological Sience 54 (3): 205\u2013208. https:\/\/doi.org\/10.1016\/j.jdermsci.2008.12.012.","journal-title":"Journal of Dermatological Sience"},{"issue":"4","key":"1805_CR23","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1159\/000447855","volume":"39","author":"X Li","year":"2016","unstructured":"Li, X., D. Han, Z. Tian, et al. 2016. Activation of Cannabinoid Receptor Type II by AM1241 Ameliorates Myocardial Fibrosis via Nrf2-Mediated Inhibition of TGF-\u03b21\/Smad3 Pathway in Myocardial Infarction Mice. Cellular Physiology and Biochemistry 39 (4): 1521\u20131536. https:\/\/doi.org\/10.1159\/000447855.","journal-title":"Cellular Physiology and Biochemistry"},{"issue":"11","key":"1805_CR24","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1111\/bph.12607","volume":"171","author":"S Zoppi","year":"2014","unstructured":"Zoppi, S., J.L. Madrigal, J.R. Caso, et al. 2014. Regulatory role of the cannabinoid CB2 receptor in stress-induced neuroinflammation in mice. British Journal of Pharmacology 171 (11): 2814\u20132826. https:\/\/doi.org\/10.1111\/bph.12607.","journal-title":"British Journal of Pharmacology"},{"key":"1805_CR25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.lfs.2019.05.056","volume":"230","author":"M Zhang","year":"2019","unstructured":"Zhang, M., M. Zhang, L. Wang, et al. 2019. Activation of cannabinoid type 2 receptor protects skeletal muscle from ischemia-reperfusion injury partly via Nrf2 signaling. Life Sciences 230: 55\u201367. https:\/\/doi.org\/10.1016\/j.lfs.2019.05.056.","journal-title":"Life Sciences"},{"key":"1805_CR26","doi-asserted-by":"publisher","first-page":"153054","DOI":"10.1016\/j.phymed.2019.153054","volume":"64","author":"L Yue","year":"2019","unstructured":"Yue, L., W. Ailin, Z. Jinwei, et al. 2019. PSORI-CM02 ameliorates psoriasis in vivo and in vitro by inducing autophagy via inhibition of the PI3K\/Akt\/mTOR pathway. Phytomedicine 64: 153054. https:\/\/doi.org\/10.1016\/j.phymed.2019.153054.","journal-title":"Phytomedicine"},{"issue":"2","key":"1805_CR27","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1365-2133.1992.tb07805.x","volume":"126","author":"BS Baker","year":"1992","unstructured":"Baker, B.S., L. Brent, H. Valdimarsson, et al. 1992. Is epidermal cell proliferation in psoriatic skin grafts on nude mice driven by T-cell derived cytokines? British Journal of Dermatology 126 (2): 105\u2013110. https:\/\/doi.org\/10.1111\/j.1365-2133.1992.tb07805.x.","journal-title":"British Journal of Dermatology"},{"issue":"7","key":"1805_CR28","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin, J., I. Arganda-Carreras, E. Frise, et al. 2012. Fiji: an open-source platform for biological-image analysis. Nature Methods 9 (7): 676\u2013682. https:\/\/doi.org\/10.1038\/nmeth.2019.","journal-title":"Nature Methods"},{"issue":"11","key":"1805_CR29","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1038\/s41419-018-1143-3","volume":"9","author":"L Mercurio","year":"2018","unstructured":"Mercurio, L., M. Morelli, C. Scarponi, et al. 2018. IL-38 has an anti-inflammatory action in psoriasis and its expression correlates with disease severity and therapeutic response to anti-IL-17A treatment. Cell Death & Disease 9 (11): 1104. https:\/\/doi.org\/10.1038\/s41419-018-1143-3.","journal-title":"Cell Death & Disease"},{"issue":"5","key":"1805_CR30","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1111\/bjd.17852","volume":"181","author":"HJ Shi","year":"2019","unstructured":"Shi, H.J., H. Zhou, A.L. Ma, et al. 2019. Oxymatrine therapy inhibited epidermal cell proliferation and apoptosis in severe plaque psoriasis. British Journal of Dermatology 181 (5): 1028\u20131037. https:\/\/doi.org\/10.1111\/bjd.17852.","journal-title":"British Journal of Dermatology"},{"issue":"1","key":"1805_CR31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41419-019-2212-y","volume":"11","author":"S Thatikonda","year":"2020","unstructured":"Thatikonda, S., V. Pooladanda, D.K. Sigalapalli, et al. 2020. Piperlongumine regulates epigenetic modulation and alleviates psoriasis-like skin inflammation via inhibition of hyperproliferation and inflammation. Cell Death & Disease 11 (1): 21. https:\/\/doi.org\/10.1038\/s41419-019-2212-y.","journal-title":"Cell Death & Disease"},{"key":"1805_CR32","doi-asserted-by":"publisher","first-page":"117115","DOI":"10.1016\/j.lfs.2019.117115","volume":"241","author":"S Wu","year":"2020","unstructured":"Wu, S., M. Zhao, Y. Sun, et al. 2020. The potential of Diosgenin in treating psoriasis: Studies from HaCaT keratinocytes and imiquimod-induced murine model. Life Sciences 241: 117115. https:\/\/doi.org\/10.1016\/j.lfs.2019.117115.","journal-title":"Life Sciences"},{"issue":"11","key":"1805_CR33","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1021\/jm061195+","volume":"50","author":"GM Giblin","year":"2007","unstructured":"Giblin, G.M., C.T. O\u2019Shaughnessy, A. Naylor, et al. 2007. Discovery of 2-[(2,4-dichlorophenyl)amino]-N-[(tetrahydro- 2H-pyran-4-yl)methyl]-4-(trifluoromethyl)- 5-pyrimidinecarboxamide, a selective CB2 receptor agonist for the treatment of inflammatory pain. Journal Of Medicinal Chemistry 50 (11): 2597\u20132600. https:\/\/doi.org\/10.1021\/jm061195+.","journal-title":"Journal Of Medicinal Chemistry"},{"issue":"8","key":"1805_CR34","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1097\/AJP.0b013e318219799a","volume":"27","author":"T Ostenfeld","year":"2011","unstructured":"Ostenfeld, T., J. Price, M. Albanese, et al. 2011. A randomized, controlled study to investigate the analgesic efficacy of single doses of the cannabinoid receptor-2 agonist GW842166, ibuprofen or placebo in patients with acute pain following third molar tooth extraction. The Clinical Journal of Pain 27 (8): 668\u2013676. https:\/\/doi.org\/10.1097\/AJP.0b013e318219799a.","journal-title":"The Clinical Journal of Pain"},{"issue":"12","key":"1805_CR35","doi-asserted-by":"publisher","first-page":"3548","DOI":"10.3390\/cells10123548","volume":"10","author":"H Yu","year":"2021","unstructured":"Yu, H., X. Liu, B. Chen, et al. 2021. The Neuroprotective Effects of the CB2 Agonist GW842166x in the 6-OHDA Mouse Model of Parkinson\u2019s Disease. Cells 10 (12): 3548. https:\/\/doi.org\/10.3390\/cells10123548.","journal-title":"Cells"},{"issue":"8","key":"1805_CR36","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.3390\/biomedicines10081776","volume":"10","author":"X Liu","year":"2022","unstructured":"Liu, X., H. Yu, B. Chen, et al. 2022. CB2 Agonist GW842166x Protected against 6-OHDA-Induced Anxiogenic- and Depressive-Related Behaviors in Mice. Biomedicines 10 (8): 1776. https:\/\/doi.org\/10.3390\/biomedicines10081776.","journal-title":"Biomedicines"},{"issue":"1","key":"1805_CR37","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s40659-020-00316-0","volume":"53","author":"J Gao","year":"2020","unstructured":"Gao, J., F. Chen, H. Fang, et al. 2020. Daphnetin inhibits proliferation and inflammatory response in human HaCaT keratinocytes and ameliorates imiquimod-induced psoriasis-like skin lesion in mice. Biological Research 53 (1): 48. https:\/\/doi.org\/10.1186\/s40659-020-00316-0.","journal-title":"Biological Research"},{"issue":"1","key":"1805_CR38","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41419-022-04523-3","volume":"13","author":"X Zhou","year":"2022","unstructured":"Zhou, X., Y. Chen, L. Cui, et al. 2022. Advances in the pathogenesis of psoriasis: from keratinocyte perspective. Cell Death & Disease 13 (1): 81. https:\/\/doi.org\/10.1038\/s41419-022-04523-3.","journal-title":"Cell Death & Disease"},{"issue":"3","key":"1805_CR39","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/1346-8138.14139","volume":"45","author":"E Ogawa","year":"2018","unstructured":"Ogawa, E., Y. Sato, A. Minagawa, et al. 2018. Pathogenesis of psoriasis and development of treatment. The Journal of Dermatology 45 (3): 264\u2013272. https:\/\/doi.org\/10.1111\/1346-8138.14139.","journal-title":"The Journal of Dermatology"},{"issue":"23","key":"1805_CR40","doi-asserted-by":"publisher","first-page":"12793","DOI":"10.3390\/ijms222312793","volume":"22","author":"R Singh","year":"2021","unstructured":"Singh, R., S. Koppu, P.O. Perche, et al. 2021. The Cytokine Mediated Molecular Pathophysiology of Psoriasis and Its Clinical Implications. International Journal of Molecular Sciences 22 (23): 12793. https:\/\/doi.org\/10.3390\/ijms222312793.","journal-title":"International Journal of Molecular Sciences"},{"issue":"3","key":"1805_CR41","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.jid.2021.06.019","volume":"142","author":"RS Gangwar","year":"2022","unstructured":"Gangwar, R.S., J.E. Gudjonsson, and N.L. Ward. 2022. Mouse Models of Psoriasis: A Comprehensive Review. Journal of Investigative Dermatology 142 (3): 884\u2013897. https:\/\/doi.org\/10.1016\/j.jid.2021.06.019.","journal-title":"Journal of Investigative Dermatology"},{"issue":"3","key":"1805_CR42","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.jid.2016.10.024","volume":"137","author":"JE Hawkes","year":"2017","unstructured":"Hawkes, J.E., J.E. Gudjonsson, and N.L. Ward. 2017. The Snowballing Literature on Imiquimod-Induced Skin Inflammation in Mice: A Critical Appraisal. Journal of Investigative Dermatology 137 (3): 546\u2013549. https:\/\/doi.org\/10.1016\/j.jid.2016.10.024.","journal-title":"Journal of Investigative Dermatology"},{"key":"1805_CR43","doi-asserted-by":"publisher","first-page":"635076","DOI":"10.3389\/fimmu.2021.635076","volume":"12","author":"S Zhang","year":"2021","unstructured":"Zhang, S., J. Zhang, J. Yu, et al. 2021. Hyperforin ameliorates imiquimod-induced psoriasis-like murine skin inflammation by modulating IL-17A-producing \u03b3\u03b4 T Cells. Frontiers in Immunology 12: 635076. https:\/\/doi.org\/10.3389\/fimmu.2021.635076.","journal-title":"Frontiers in Immunology"},{"issue":"9","key":"1805_CR44","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","volume":"182","author":"L van der Fits","year":"2009","unstructured":"van der Fits, L., S. Mourits, J.S. Voerman, et al. 2009. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis. Journal of Immunology 182 (9): 5836\u20135845. https:\/\/doi.org\/10.4049\/jimmunol.0802999.","journal-title":"Journal of Immunology"},{"issue":"4","key":"1805_CR45","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/exd.12649","volume":"24","author":"DF Frenzel","year":"2015","unstructured":"Frenzel, D.F., L. Borkner, J. Scheurmann, et al. 2015. Osteopontin deficiency affects imiquimod-induced psoriasis-like murine skin inflammation and lymphocyte distribution in skin, draining lymph nodes and spleen. Experimental Dermatology 24 (4): 305\u2013307. https:\/\/doi.org\/10.1111\/exd.12649.","journal-title":"Experimental Dermatology"},{"key":"1805_CR46","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.3389\/fimmu.2017.01767","volume":"8","author":"H Chen","year":"2017","unstructured":"Chen, H., H. Liu, C. Lu, et al. 2017. PSORI-CM02 Formula Increases CD4+ Foxp3+ Regulatory T Cell Frequency and Ameliorates Imiquimod-Induced Psoriasis in Mice. Frontiers in Immunology 8: 1767. https:\/\/doi.org\/10.3389\/fimmu.2017.01767.","journal-title":"Frontiers in Immunology"},{"issue":"4","key":"1805_CR47","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1111\/bjd.16560","volume":"179","author":"K Yan","year":"2018","unstructured":"Yan, K., W. Xu, Y. Huang, et al. 2018. Methotrexate restores the function of peripheral blood regulatory T cells in psoriasis vulgaris via the CD73\/AMPK\/mTOR pathway. British Journal of Pharmacology 179 (4): 896\u2013905. https:\/\/doi.org\/10.1111\/bjd.16560.","journal-title":"British Journal of Pharmacology"},{"key":"1805_CR48","doi-asserted-by":"publisher","first-page":"117231","DOI":"10.1016\/j.lfs.2019.117231","volume":"243","author":"L Li","year":"2020","unstructured":"Li, L., H.Y. Zhang, X.Q. Zhong, et al. 2020. PSORI-CM02 formula alleviates imiquimod-induced psoriasis via affecting macrophage infiltration and polarization. Life Sciences 243: 117231. https:\/\/doi.org\/10.1016\/j.lfs.2019.117231.","journal-title":"Life Sciences"},{"key":"1805_CR49","doi-asserted-by":"publisher","first-page":"117989","DOI":"10.1016\/j.lfs.2020.117989","volume":"256","author":"P Jiang","year":"2020","unstructured":"Jiang, P., L. Wang, M. Zhang, et al. 2020. Cannabinoid type 2 receptor manipulates skeletal muscle regeneration partly by regulating macrophage M1\/M2 polarization in IR injury in mice. Life Sciences 256: 117989. https:\/\/doi.org\/10.1016\/j.lfs.2020.117989.","journal-title":"Life Sciences"},{"issue":"4","key":"1805_CR50","doi-asserted-by":"publisher","first-page":"874","DOI":"10.3390\/biomedicines10040874","volume":"10","author":"C Tortora","year":"2022","unstructured":"Tortora, C., A. Di Paola, M. Argenziano, et al. 2022. Effects of CB2 Receptor Modulation on Macrophage Polarization in Pediatric Celiac Disease. Biomedicines 10 (4): 874. https:\/\/doi.org\/10.3390\/biomedicines10040874.","journal-title":"Biomedicines"},{"issue":"2","key":"1805_CR51","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3390\/antiox11020221","volume":"11","author":"N Charachit","year":"2022","unstructured":"Charachit, N., A. Sukhamwang, P. Dejkriengkraikul, et al. 2022. Hyperoside and Quercitrin in Houttuynia cordata Extract Attenuate UVB-Induced Human Keratinocyte Cell Damage and Oxidative Stress via Modulation of MAPKs and Akt Signaling Pathway. Antioxidants 11 (2): 221. https:\/\/doi.org\/10.3390\/antiox11020221.","journal-title":"Antioxidants"},{"issue":"12","key":"1805_CR52","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.3390\/antiox10121941","volume":"10","author":"SY Kim","year":"2021","unstructured":"Kim, S.Y., S.D. Han, M. Kim, et al. 2021. Mentha arvensis Essential Oil Exerts Anti-Inflammatory in LPS-Stimulated Inflammatory Responses via Inhibition of ERK\/NF-\u03baB Signaling Pathway and Anti-Atopic Dermatitis-like Effects in 2,4-Dinitrochlorobezene-Induced BALB\/c Mice. Antioxidants 10 (12): 1941. https:\/\/doi.org\/10.3390\/antiox10121941.","journal-title":"Antioxidants"},{"issue":"Suppl 3","key":"1805_CR53","doi-asserted-by":"publisher","first-page":"iii37","DOI":"10.1136\/ard.2006.058446","volume":"65","author":"W Niedbala","year":"2006","unstructured":"Niedbala, W., B. Cai, and F.Y. Liew. 2006. Role of nitric oxide in the regulation of T cell functions. Annals of the Rheumatic Diseases 65 (Suppl 3): iii37\u2013iii40. https:\/\/doi.org\/10.1136\/ard.2006.058446.","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"7","key":"1805_CR54","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1084\/jem.20122494","volume":"210","author":"Y Jianjun","year":"2013","unstructured":"Jianjun, Y., R. Zhang, G. Lu, et al. 2013. T cell\u2013derived inducible nitric oxide synthase switches off Th17 cell differentiation. Journal of Experimental Medicine 210 (7): 1447\u20131462. https:\/\/doi.org\/10.1084\/jem.20122494.","journal-title":"Journal of Experimental Medicine"},{"issue":"1","key":"1805_CR55","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1034\/j.1600-065x.2000.917307.x","volume":"173","author":"C Bogdan","year":"2000","unstructured":"Bogdan, C., M. R\u00f6llinghoff, and A. Diefenbach. 2000. The role of nitric oxide in innate immunity. Immunological Reviews 173 (1): 17\u201326. https:\/\/doi.org\/10.1034\/j.1600-065x.2000.917307.x.","journal-title":"Immunological Reviews"},{"issue":"11","key":"1805_CR56","doi-asserted-by":"publisher","first-page":"10776","DOI":"10.1074\/jbc.M313416200","volume":"279","author":"H Xiong","year":"2004","unstructured":"Xiong, H., C. Zhu, F. Li, et al. 2004. Inhibition of interleukin-12 p40 transcription and NF-kappaB activation by nitric oxide in murine macrophages and dendritic cells. Journal of Biological Chemistry 279 (11): 10776\u201310783. https:\/\/doi.org\/10.1074\/jbc.M313416200.","journal-title":"Journal of Biological Chemistry"},{"key":"1805_CR57","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.pnpbp.2015.03.017","volume":"64","author":"Y G\u00f3mez-G\u00e1lvez","year":"2016","unstructured":"G\u00f3mez-G\u00e1lvez, Y., C. Palomo-Garo, J. Fern\u00e1ndez-Ruiz, et al. 2016. Potential of the cannabinoid CB(2) receptor as a pharmacological target against inflammation in Parkinson\u2019s disease. Progress in Neuro-Psychopharmacology and Biological Psychiatry 64: 200\u2013208. https:\/\/doi.org\/10.1016\/j.pnpbp.2015.03.017.","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"key":"1805_CR58","doi-asserted-by":"publisher","first-page":"110481","DOI":"10.1016\/j.pnpbp.2021.110481","volume":"114","author":"G Morris","year":"2022","unstructured":"Morris, G., K. Walder, M. Berk, et al. 2022. Intertwined associations between oxidative and nitrosative stress and endocannabinoid system pathways: Relevance for neuropsychiatric disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry 114: 110481. https:\/\/doi.org\/10.1016\/j.pnpbp.2021.110481.","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"key":"1805_CR59","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.phymed.2018.07.009","volume":"55","author":"S Singh","year":"2019","unstructured":"Singh, S., D.K. Singh, A. Meena, et al. 2019. Rutin protects t-butyl hydroperoxide-induced oxidative impairment via modulating the Nrf2 and iNOS activity. Phytomedicine 55: 92\u2013104. https:\/\/doi.org\/10.1016\/j.phymed.2018.07.009.","journal-title":"Phytomedicine"},{"issue":"7","key":"1805_CR60","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.3390\/antiox11071397","volume":"11","author":"T Ogawa","year":"2022","unstructured":"Ogawa, T., and Y. Ishitsuka. 2022. The Role of KEAP1-NRF2 System in Atopic Dermatitis and Psoriasis. Antioxidants 11 (7): 1397. https:\/\/doi.org\/10.3390\/antiox11071397.","journal-title":"Antioxidants"},{"key":"1805_CR61","doi-asserted-by":"publisher","DOI":"10.1002\/biof.1912","author":"E Panieri","year":"2022","unstructured":"Panieri, E., P. Telkoparan-Akillilar, and L. Saso. 2022. NRF2, a crucial modulator of skin cells protection against vitiligo, psoriasis, and cancer. Biofactors 1912. https:\/\/doi.org\/10.1002\/biof.1912.","journal-title":"Biofactors 1912"},{"issue":"3","key":"1805_CR62","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.ajpath.2019.10.022","volume":"190","author":"T Ogawa","year":"2020","unstructured":"Ogawa, T., Y. Ishitsuka, S. Inoue, et al. 2020. Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Regulates Epidermal Keratinization under Psoriatic Skin Inflammation. American Journal of Pathology 190 (3): 577\u2013585. https:\/\/doi.org\/10.1016\/j.ajpath.2019.10.022.","journal-title":"American Journal of Pathology"},{"issue":"10","key":"1805_CR63","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1016\/j.jid.2017.05.015","volume":"137","author":"L Yang","year":"2017","unstructured":"Yang, L., X. Fan, T. Cui, et al. 2017. Nrf2 Promotes Keratinocyte Proliferation in Psoriasis through Up-Regulation of Keratin 6, Keratin 16, and Keratin 17. Journal of Investigative Dermatology 137 (10): 2168\u20132176. https:\/\/doi.org\/10.1016\/j.jid.2017.05.015.","journal-title":"Journal of Investigative Dermatology"},{"issue":"2","key":"1805_CR64","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/j.1610-0387.2009.07213.x","volume":"8","author":"NQ Phan","year":"2010","unstructured":"Phan, N.Q., D. Siepmann, I. Gralow, et al. 2010. Adjuvant topical therapy with a cannabinoid receptor agonist in facial postherpetic neuralgia. Journal of the German Society of Dermatology 8 (2): 88\u201391. https:\/\/doi.org\/10.1111\/j.1610-0387.2009.07213.x.","journal-title":"Journal of the German Society of Dermatology"},{"issue":"16","key":"1805_CR65","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.3390\/cells11162569","volume":"11","author":"P Przybycie\u0144","year":"2022","unstructured":"Przybycie\u0144, P., D. G\u0105sior-Perczak, and W. Placha. 2022. Cannabinoids and PPAR Ligands: The Future in Treatment of Polycystic Ovary Syndrome Women with Obesity and Reduced Fertility. Cells 11 (16): 2569. https:\/\/doi.org\/10.3390\/cells11162569.","journal-title":"Cells"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-023-01805-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-023-01805-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-023-01805-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T07:12:31Z","timestamp":1689837151000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-023-01805-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,31]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["1805"],"URL":"https:\/\/doi.org\/10.1007\/s10753-023-01805-6","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,31]]},"assertion":[{"value":"10 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol of animal study was reviewed and approved by Laboratory Animal Welfare and Ethics Committee of Army Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"The consent of all coauthors was collected before submission.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}